Magdalena Kistowska
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial.
Journal: Clinical and translational science
Published: January 14, 2021
Malassezia yeasts activate the NLRP3 inflammasome in antigen-presenting cells via Syk-kinase signalling.
Journal: Experimental dermatology
Published: September 21, 2014
Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients.
Journal: The Journal of investigative dermatology
Published: March 28, 2014
Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages.
Journal: Journal of dermatological science
Published: October 08, 2013
IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo.
Journal: The Journal of investigative dermatology
Published: July 31, 2013
Caspase-4 is required for activation of inflammasomes.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 17, 2012
Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus.
Journal: Nature immunology
Published: December 01, 2011
Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 19, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026